Sign in
4

Changes in Ownership

Caribou Biosciences, Inc. Filed Acc 0001209191-22-016872

Chief Scientific Officer acquired 10,720 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kanner Steven Chief Scientific Officer 2022-03-04 Option exercise +9,171 $2.69 $24,670 226,090 D: show line 1 in the form
Kanner Steven Chief Scientific Officer 2022-03-04 Option exercise +1,549 $4.11 $6,366 227,639 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kanner Steven Chief Scientific Officer 2022-03-04 Option exercise · Option to purchase Common Stock −9,171 122,963 D: show line 3 in the form
Kanner Steven Chief Scientific Officer 2022-03-04 Option exercise · Option to purchase Common Stock −1,549 230,365 D: show line 4 in the form
Loading xslF345X03/doc4.xml…